Antivirals/anti-infectives
date: 02/04/2025
New information on approved medicines
- Xydalba (dalbavancin) - extension of indication
Treatment of acute bacterial infection of the skin and skin structures
Direct Healthcare Professional Communication (DHPC)
- Emblaveo (Avibactam / Aztreonam): 1.5 g/0.5 g powder for concentrate for solution for infusion: potential for cracked or broken vials
Treatment of different types of bacterial infections